Proteome SciencesPMSNF Days Payable is 100.16 as of Dec. 2025, which is 62% above its 10-year median of 61.97. The stock has 6 warning signs investors should review. Among 191 Medical Diagnostics & Research companies, Proteome Sciences ranks better than 63.87% on this metric.
The historical rank and industry rank for Proteome Sciences's Days Payable or its related term are showing as below:
PMSNF'
s Days Payable Range Over the Past 10 Years
Min: 7.02 Med: 61.97 Max: 99.98
Current: 99.98
During the past 13 years, Proteome Sciences's highest Days Payable was 99.98. The lowest was 7.02. And the median was 61.97.
PMSNF's Days Payable is ranked better than 63.87% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.87
vs PMSNF: 99.98
Proteome Sciences's Days Payable
increased
from Dec. 2024 (54.58) to Dec. 2025 (100.16).
It may suggest that Proteome Sciencesdelayed paying its suppliers.
Proteome Sciences Days Payable Related Terms
Proteome Sciences Days Payable Historical Data
* Premium members only.
The historical data trend for Proteome Sciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Proteome Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Proteome Sciences Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Proteome Sciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Proteome Sciences's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Proteome Sciences (PMSNF) has a Days Payable of 100.16 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Proteome Sciences and its competitors. This is 62% above median its historical median of 61.97. Over the past decade, Proteome Sciences' Days Payable has ranged from 7.02 to 99.98. According to the industry distribution chart, Proteome Sciences ranks #69 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 36.1%.
Is Proteome Sciences' Days Payable too high?
Proteome Sciences' current Days Payable of 100.16 is 62% above median its 10-year median of 61.97. Over the past 10 years, this metric has ranged from a low of 7.02 to a high of 99.98. The Medical Diagnostics & Research industry median Days Payable is 68.87. Proteome Sciences' value of 100.16 is 45.4% above this industry median. Based on the distribution chart, Proteome Sciences ranks #69 out of 191 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Proteome Sciences' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #69 out of 191 companies for Days Payable. This puts Proteome Sciences in the upper half of its industry. The industry median Days Payable is 68.87. Proteome Sciences' value of 100.16 is 45.4% above this benchmark. Historically, Proteome Sciences' own Days Payable has ranged from 7.02 to 99.98 over the past decade. While the company's 10-year median is 61.97 vs. the industry median of 68.87, Proteome Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 68.87, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Proteome Sciences's current Days Payable of 100.16 is 45.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Proteome Sciences and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 68.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Proteome Sciences's current Days Payable is 100.16, which is 62% above median its own 10-year median of 61.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Proteome Sciences (PMSNF) has a current Days Payable of 100.16. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 17.5% below its estimated fair value. The current Days Payable is 100.16, which is 62% above median its 10-year median of 61.97 and 45.4% above the Medical Diagnostics & Research industry median of 68.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Proteome Sciences (PMSNF), the current Days Payable is 100.16 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMSNF has been successfully added to your 